View Item 

Show simple item record

Limited granulomatosis with polyangiitis in an adolescent with Crohn's disease on infliximab therapy: cause or coincidence?

dc.contributor.authorArora, Harbiren_US
dc.contributor.authorMadani, Shailenderen_US
dc.contributor.authorDebelenko, Larisa V.en_US
dc.contributor.authorMcGrath, Eric J.en_US
dc.contributor.authorMutyala, Ramakrishnaen_US
dc.contributor.authorGuglani, Lokeshen_US
dc.date.accessioned2015-11-12T21:03:42Z
dc.date.available2016-12-01T14:33:05Zen
dc.date.issued2015-10en_US
dc.identifier.citationArora, Harbir; Madani, Shailender; Debelenko, Larisa V.; McGrath, Eric J.; Mutyala, Ramakrishna; Guglani, Lokesh (2015). "Limited granulomatosis with polyangiitis in an adolescent with Crohn's disease on infliximab therapy: cause or coincidence?." The Clinical Respiratory Journal 9(4): 506-511.en_US
dc.identifier.issn1752-6981en_US
dc.identifier.issn1752-699Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/115908
dc.description.abstractPulmonary involvement in Crohn's disease (CD) may precede the development of intestinal inflammation, but in most cases occurs during the course of treatment, either as an extra‐intestinal manifestation, because of secondary infections, or as a side effect of the therapy itself. This case highlights the differential diagnosis and work up for multiple pulmonary nodules that developed in a patient with CD who had been in remission on infliximab therapy. Even though infectious causes, such as Mycobacteria and Fungi, account for majority of these cases, the possibility of non‐infectious conditions such as autoimmune disorders should also be considered.en_US
dc.publisherSpringeren_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherlung biopsyen_US
dc.subject.otherlung diseaseen_US
dc.subject.otherpulmonary nodulesen_US
dc.subject.otherCrohn's diseaseen_US
dc.subject.otheradverse effectsen_US
dc.subject.othertumor necrosis factoren_US
dc.subject.othergranulomaen_US
dc.subject.otherinflammatory bowel diseaseen_US
dc.subject.otherinfliximaben_US
dc.titleLimited granulomatosis with polyangiitis in an adolescent with Crohn's disease on infliximab therapy: cause or coincidence?en_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPulmonary Medicineen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/115908/1/crj12168.pdf
dc.identifier.doi10.1111/crj.12168en_US
dc.identifier.sourceThe Clinical Respiratory Journalen_US
dc.identifier.citedreferenceHeraganahally SS, Au V, Kondru S, Edwards S, Bowden JJ, Sajkov D. Pulmonary toxicity associated with infliximab therapy for ulcerative colitis. Intern Med J. 2009; 39 ( 9 ): 629 – 630.en_US
dc.identifier.citedreferenceKhor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011; 474 ( 7351 ): 307 – 317.en_US
dc.identifier.citedreferenceBaran B, Karaca C. Practical medical management of Crohn's disease. ISRN Gastroenterol. 2013; 2013: 208073; doi: http://dx.doi.org/ 10.1155/2013/208073.en_US
dc.identifier.citedreferenceFeagan BG, McDonald JW, Panaccione R, et al. Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's disease. Gastroenterology. 2014; 146: 681 – 88 e1.en_US
dc.identifier.citedreferenceLevenbrown Y, Tauber D, Hall OR, Baldridge AD. Granulomatous lung disease as the initial presentation of Crohn's disease. J Pediatr Gastroenterol Nutr. 2009; 48 ( 4 ): 487 – 490.en_US
dc.identifier.citedreferenceKrishnan S, Banquet A, Newman L, Katta U, Patil A, Dozor AJ. Lung lesions in children with Crohn's disease presenting as nonresolving pneumonias and response to infliximab therapy. Pediatrics. 2006; 117 ( 4 ): 1440 – 1443.en_US
dc.identifier.citedreferencePanagi S, Palka W, Korelitz BI, Taskin M, Lessnau KD. Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease. Inflamm Bowel Dis. 2004; 10 ( 3 ): 274 – 277.en_US
dc.identifier.citedreferenceMukhopadhyay S, Gal AA. Granulomatous lung disease: an approach to the differential diagnosis. Arch Pathol Lab Med. 2010; 134 ( 5 ): 667 – 690.en_US
dc.identifier.citedreferenceMukhopadhyay S. Role of histology in the diagnosis of infectious causes of granulomatous lung disease. Curr Opin Pulm Med. 2011; 17 ( 3 ): 189 – 196.en_US
dc.identifier.citedreferencePuntis JW, Tarlow MJ, Raafat F, Booth IW. Crohn's disease of the lung. Arch Dis Child. 1990; 65 ( 11 ): 1270 – 1271.en_US
dc.identifier.citedreferenceTomasefski JF, Cagle PT, Farver CF, Fraire AE. Dail and Hammar's Pulmonary Pathology Volume 1: Non Neoplastic Lung Disease. New York, Springer, 2008.en_US
dc.identifier.citedreferenceCasey MB, Tazelaar HD, Myers JL, Hunninghake GW, Kakar S, Kalra SX, Ashton R, Colby TV. Noninfectious lung pathology in patients with Crohn's disease. Am J Surg Pathol. 2003; 27 ( 2 ): 213 – 219.en_US
dc.identifier.citedreferenceAlskaf E, Aljoudeh A, Edenborough F. Mesalazine‐induced lung fibrosis. BMJ Case Rep. 2013; doi: 10.1136/bcr‐2013‐008724.en_US
dc.identifier.citedreferenceTayer‐Shifman OE, Shuvy M, Hershko AY. Mesalamine‐induced multiple pulmonary cavitary nodules associated with cytoplasmic antineutrophil cytoplasmic antibody (c‐ANCA). J Clin Rheumatol. 2009; 15 ( 5 ): 256 – 257.en_US
dc.identifier.citedreferenceMuller A, Lamprecht P. [Interleukin‐17 in chronic inflammatory and autoimmune diseases: rheumatoid arthritis, Crohn's disease and Wegener's granulomatosis]. Z Rheumatol. 2008; 67 ( 1 ): 72 – 74.en_US
dc.identifier.citedreferenceRamos‐Casals M, Brito‐Zeron P, Munoz S, Soria N, Galiana D, Bertolaccini L, Cuadrado MJ, Khamashta MA. Autoimmune diseases induced by TNF‐targeted therapies: analysis of 233 cases. Medicine (Baltimore). 2007; 86 ( 4 ): 242 – 251.en_US
dc.identifier.citedreferenceLim LT, Ruzmetova N, Ballinger SH, Moorthy RS. Acute pulmonary histoplasmosis in a patient with uveitis after infliximab therapy. Int Ophthalmol. 2011; 31 ( 4 ): 349 – 351.en_US
dc.identifier.citedreferenceWarris A, Bjorneklett A, Gaustad P. Invasive pulmonary aspergillosis associated with infliximab therapy. N Engl J Med. 2001; 344 ( 14 ): 1099 – 1100.en_US
dc.identifier.citedreferenceHirai F, Matsui T, Ishibashi Y, Higashi D, Futami K, Haraoka S, Iwashita A. Asymptomatic pulmonary cryptococcosis in a patient with Crohn's disease on infliximab: case report. Inflamm Bowel Dis. 2011; 17 ( 7 ): 1637 – 1638.en_US
dc.identifier.citedreferenceCaccaro R, Savarino E, D'Inca R, Sturniolo GC. Noninfectious interstitial lung disease during infliximab therapy: case report and literature review. World J Gastroenterol. 2013; 19 ( 32 ): 5377 – 5380.en_US
dc.identifier.citedreferenceSen S, Peltz C, Jordan K, Boes TJ. Infliximab‐induced nonspecific interstitial pneumonia. Am J Med Sci. 2012; 344 ( 1 ): 75 – 78.en_US
dc.identifier.citedreferenceMcIlwain L, Carter JD, Bin‐Sagheer S, Vasey FB, Nord J. Hypersensitivity vasculitis with leukocytoclastic vasculitis secondary to infliximab. J Clin Gastroenterol. 2003; 36 ( 5 ): 411 – 413.en_US
dc.identifier.citedreferenceKaroui S, Bibani N, Ben Gorbel I, Serghini M, Mlika M, Braham A, Chelly I, Haouet S, Houmene H, Filali A. Leukocytoclastic vasculitis: a rare adverse effect secondary to infliximab. Inflamm Bowel Dis. 2011; 17 ( 2 ): E4 – 5.en_US
dc.identifier.citedreferenceSieczkowska A, Lewandowski P, Szumera M, Kaminska B. [Coexistence of Crohn disease and Wegener granulomatosis in a 15‐year‐old patient]. Med Wieku Rozwoj. 2011; 15 ( 4 ): 472 – 476.en_US
dc.identifier.citedreferenceCodish S, Abu‐Shakra M, Depsames R, Sion‐Vardy N, Benharroch D, Sukenik S. Wegener's granulomatosis in a patient with Crohn's disease. Isr Med Assoc J. 2000; 2 ( 8 ): 630 – 631.en_US
dc.identifier.citedreferenceStone JH. Wegener's Granulomatosis Etanercept Trial Research G. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial. Arthritis Rheum. 2003; 48 ( 8 ): 2299 – 2309.en_US
dc.identifier.citedreferenceKim HW, Kim JW, Im CH, Shin KC, Lee EY, Lee EB, Song YW. The clinicopathologic characteristics of granulomatosis with polyangiitis (Wegener's): a retrospective study of 45 patients in Korea. Mod Rheumatol. 2013; 23 ( 5 ): 864 – 871.en_US
dc.identifier.citedreferenceLeavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990; 33 ( 8 ): 1101 – 1107.en_US
dc.identifier.citedreferenceJennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994; 37 ( 2 ): 187 – 192.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
crj12168.pdf
Size:
332.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.